NHS targets to flourish under ‘arch moderniser
October 29, 2003New Health Secretary Dr John Reid has committed the NHS to continued reform despite a growing chorus of disapproval over …
AZ settles $355m fraud case
October 29, 2003AstraZeneca has settled the case relating to fraudulent sales of its prostate cancer drug Zoladex, and will pay a total …
Department of Health takes a dose of its own medicine
October 29, 2003The Department of Health is to open itself up to the same adical transformationit is overseeing in the NHS by …
Final battle for future of US healthcare draws near
October 29, 2003The future of the US healthcare system and how patients pay for their medicines will be decided in the coming …
Pfizer cool on Prilosec OTC launch
October 29, 2003Pfizer has criticised the US approval of an over-the-counter formulation of AstraZeneca's heartburn drug Prilosec, saying it will only serve …
Biotech consolidation picks up with $6.4bn deal
October 29, 2003The recent run of biotech consolidation has stepped up a gear as Biogen and Idec have agreed a $6.4 billion …
Foundation status reform not most important, say trusts
October 29, 2003The Government's plans for foundations hospitals will have much less impact on the NHS than other reforms of the health …
Novartis buys Pfizer incontinence drug
October 29, 2003Novartis has bought Pfizer's incontinence product Enablex ahead of the US giant's merger with Pharmacia.The drug is one of several …
Look closer – The importance of local opinion leaders
October 29, 2003Sales and Marketing key opinion leaders
There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …
Roche survey shows cancer postcode prescribing continues
October 29, 2003A new UK-wide survey by Roche has shown a third of breast cancer patients who could benefit from its NICE-approved …
Limited lifting of NICE ‘ban’ on Tamiflu
October 29, 2003Sales and Marketing
Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …
The new GP contract : incentives for pharma too
October 29, 2003GP contract, NHS, healthcare
As the final details of the new GP contract are decided, the pharmaceutical industry is now preparing itself for a …
Betaferon and Avonex in head-to-head MS trial
October 29, 2003Research and Development, Sales and Marketing
Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
